Canada markets closed

Gene Biotherapeutics, Inc. (CRXM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 09:30AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
Total Revenue
0
0
Operating Expenses
Research Development
217.582
217.582
Selling General and Administrative
1,045
1,045
Total Operating Expenses
1,262
1,262
Operating Income or Loss
-1,262
-1,262
Interest Expense
57.4
57.4
Total Other Income/Expenses Net
-173.555
668.032
Income Before Tax
-651.55
-651.55
Income from Continuing Operations
-651.55
-651.55
Net Income
-517.897
-517.897
Net Income available to common shareholders
-517.897
-517.897
Basic EPS
-0.02
-
Diluted EPS
-0.02
-
Basic Average Shares
24,116
-
Diluted Average Shares
24,116
-